Trials / Completed
CompletedNCT02548338
Argon Plasma Coagulation Scalpel on Surgical Treatment of Breast Cancer
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Federal University of São Paulo · Academic / Other
- Sex
- Female
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are selecting sixty (60) with breast cancer diagnoses where the surgical treatment is indicated.Furthermore the investigators divided in two groups : 1) surgical treatment using regular electric scalpel ; 2) surgical treatment using argon plasma coagulation scalpel. Our primary goal is to measure the bleeding during the surgery using the weight of the surgical tissues used. Secondary we'll evaluate the immediate post operative outcomes, like infection, hematomas and seromas. All these variables will be evaluated by a doctor using our standard clinical record and it will be measured using reliable parameters, for exemple: if the investigators clinically detect a hematoma then we'll perform an ultrasound to take the real extension; if the investigators clinically pick an infection we'll measure the extension of the hiperemia; and if the investigators clinically pick a seroma we'll drain and quantify it. Secondary the investigators going to evaluate and measure (centimeters) the terminal damage caused on the surgical specimens (samples) using the microscope.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | argon plasma coagulation | On the first group we use the regular electric scalpel to perform the surgery , and on the second group we use the argon plasma coagulation scalpel to perform the procedure. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2014-11-01
- Completion
- 2015-04-01
- First posted
- 2015-09-14
- Last updated
- 2015-09-14
Source: ClinicalTrials.gov record NCT02548338. Inclusion in this directory is not an endorsement.